To the Editor I read the article by Caldeira et al1 with great interest. However, some information given by the authors needs some critical discussion and verification.
The authors wrote, “Published consensus-based guidance specifically for the management of NOACs [novel oral anticoagulants] does not support the withdrawal of anticoagulation in patients undergoing cataract or glaucoma interventions,”1 and they cited the article titled “European Heart Rhythm Association Practical Guide on the Use of New Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation” by Heidbuchel et al.2
Grzybowski A. Glaucoma Surgery and Anticoagulant Therapy. JAMA Ophthalmol. 2015;133(11):1364–1365. doi:10.1001/jamaophthalmol.2015.3071
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: